| Literature DB >> 10895140 |
Abstract
While early success rates using in vitro fertilisation ranged from 10% to 15%, improved technology has more than doubled that rate, owing to the availability of recombinant follicle-stimulating hormone, improved ovarian stimulation protocols, and assisted fertilisation technology. This latter technology has already revolutionised the management of male-factor infertility. The future goal is to further increase the overall pregnancy rate and to reduce the risk of multiple gestation by using pre-implantation genetic diagnosis and blastocyst transfer.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10895140
Source DB: PubMed Journal: Hong Kong Med J ISSN: 1024-2708 Impact factor: 2.227